99.96
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$99.17
Offen:
$99.19
24-Stunden-Volumen:
1.01M
Relative Volume:
0.49
Marktkapitalisierung:
$15.36B
Einnahmen:
$4.28B
Nettoeinkommen (Verlust:
$1.26B
KGV:
12.65
EPS:
7.9
Netto-Cashflow:
$943.00M
1W Leistung:
-1.81%
1M Leistung:
-8.05%
6M Leistung:
+12.35%
1J Leistung:
-25.28%
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Vergleichen Sie ILMN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ILMN
Illumina Inc
|
99.96 | 15.70B | 4.28B | 1.26B | 943.00M | 7.90 |
![]()
TMO
Thermo Fisher Scientific Inc
|
492.72 | 184.93B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
205.82 | 147.00B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
647.09 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
125.66 | 35.50B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
190.81 | 32.08B | 15.70B | 1.24B | 2.01B | 6.91 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-12 | Herabstufung | Daiwa Securities | Outperform → Neutral |
2025-07-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
2025-03-04 | Bestätigt | Citigroup | Neutral |
2025-02-28 | Herabstufung | HSBC Securities | Buy → Hold |
2025-02-10 | Herabstufung | Barclays | Equal Weight → Underweight |
2025-02-07 | Herabstufung | TD Cowen | Buy → Hold |
2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
2024-08-28 | Hochstufung | Argus | Hold → Buy |
2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
2024-06-03 | Fortgesetzt | Jefferies | Hold |
2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
2023-12-14 | Eingeleitet | Guggenheim | Buy |
2023-12-14 | Eingeleitet | Stephens | Overweight |
2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
2023-09-28 | Eingeleitet | Bernstein | Underperform |
2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
2023-01-25 | Herabstufung | Argus | Buy → Hold |
2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
2022-01-18 | Hochstufung | Stifel | Hold → Buy |
2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
2021-10-15 | Fortgesetzt | Cowen | Outperform |
2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
2021-03-03 | Eingeleitet | Barclays | Underweight |
2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2020-09-22 | Herabstufung | Stifel | Buy → Hold |
2020-09-22 | Herabstufung | UBS | Buy → Neutral |
2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
2020-01-07 | Eingeleitet | Citigroup | Buy |
2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
2019-11-15 | Eingeleitet | Stifel | Buy |
2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term - sharewise.com
Ranking Illumina Inc. among high performing stocks via toolsQuarterly Profit Review & Weekly High Potential Stock Alerts - Newser
Illumina Inc. stock daily chart insightsJuly 2025 Closing Moves & Momentum Based Trading Signals - Newser
Can you recover from losses in Illumina Inc.July 2025 Summary & Verified Momentum Watchlists - Newser
Aug Weekly: Will Illumina Inc. announce a stock split2025 Volatility Report & Risk Managed Trade Strategies - خودرو بانک
What momentum shifts mean for Illumina Inc.July 2025 Gainers & Consistent Growth Equity Picks - Newser
Can Illumina Inc. hit a new high this monthPortfolio Performance Report & AI Enhanced Trade Execution Alerts - Newser
Illumina Inc. stock trend forecastPortfolio Update Report & Free Expert Verified Stock Movement Alerts - Newser
Life Sciences Tools & Services Stocks Q2 Results: Benchmarking Illumina (NASDAQ:ILMN) - FinancialContent
Smart tools for monitoring Illumina Inc.’s price actionPortfolio Update Summary & Proven Capital Preservation Methods - Newser
What institutional flow reveals about Illumina Inc.2025 Breakouts & Breakdowns & Consistent Profit Alerts - Newser
Best data tools to analyze Illumina Inc. stock2025 Buyback Activity & Free Long-Term Investment Growth Plans - Newser
Will Illumina Inc. benefit from macro trendsExit Point & Risk Controlled Swing Alerts - Newser
Risk adjusted return profile for Illumina Inc. analyzedPortfolio Performance Report & Long-Term Growth Portfolio Plans - Newser
Using portfolio simulators with Illumina Inc. includedQuarterly Earnings Report & Safe Capital Growth Tips - Newser
How institutional ownership impacts Illumina Inc. stockJuly 2025 Momentum & Low Risk High Reward Trade Ideas - Newser
Using AI based signals to follow Illumina Inc.July 2025 PreEarnings & Verified Momentum Stock Watchlist - Newser
Real time social sentiment graph for Illumina Inc.Forecast Cut & Daily Risk Controlled Trade Plans - Newser
Real time breakdown of Illumina Inc. stock performanceVolume Spike & Verified Chart Pattern Signals - Newser
Forecasting Illumina Inc. price range with options dataJuly 2025 Sentiment & Free Reliable Trade Execution Plans - Newser
Live market analysis of Illumina Inc.Portfolio Performance Report & Verified Chart Pattern Signals - Newser
Will Illumina Inc. stock recover after recent dropWeekly Market Summary & Reliable Intraday Trade Alerts - Newser
What to expect from Illumina Inc. in the next 30 daysQuarterly Earnings Report & Expert Curated Trade Ideas - Newser
Detecting price anomalies in Illumina Inc. with AIEarnings Risk Summary & Free High Return Stock Watch Alerts - Newser
Chart based exit strategy for Illumina Inc.2025 Key Lessons & Weekly Watchlist for Hot Stocks - Newser
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):